Cover Image

Application of clinical decision support tools for predicting outcomes with vedolizumab therapy in patients with inflammatory bowel disease: A KASID multicentre study

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Kyuwon Kim, Jae Jun Park, Hyuk Yoon, Jun Lee, Kyeong Ok Kim, Eun Sun Kim, Su Young Kim, Sun‐Jin Boo, Yunho Jung, Jun Hwan Yoo, Sung Wook Hwang, Sang Hyoung Park, Suk‐Kyun Yang, Byong Duk Ye
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Alimentary Pharmacology & Therapeutics
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Editorial: Another brick in the CDST wall: Authors' reply
by: Kyuwon Kim, et al.
Published: (2024)

Editorial: To Stop or Not to Stop, Is It Still a Question? Authors' Reply
by: Jeongkuk Seo, et al.
Published: (2024)

Robust Predictive Performance of the SALT‐M Score for Clinical Outcomes in Asian Patients With Acute‐on‐Chronic Liver Failure
by: Kunhee Kim, et al.
Published: (2024)

Clinical Course and Prognosis of Long‐Term Survivors of Hepatocellular Carcinoma
by: Soon Sun Kim, et al.
Published: (2025)

Letter: Towards Better Intervention Strategies for MASLD and MetALD—What Are We Missing? Authors' Reply
by: Yewan Park, et al.
Published: (2024)

Review article: Prevention of inflammatory bowel disease—The path forward
by: Sérgio Bronze, et al.
Published: (2024)

Impact of inflammatory bowel disease on the risk of acute coronary syndrome: A Swedish Nationwide Cohort Study
by: Carl Eriksson, et al.
Published: (2024)

Editorial: GLP‐1 receptor agonists in inflammatory bowel disease—Is it time?
by: Konstantinos Arvanitakis, et al.
Published: (2024)

Review article: Novel therapies in inflammatory bowel disease – An update for clinicians
by: Nurulamin M. Noor, et al.
Published: (2024)

Meta‐analysis: Persistence of advanced therapies in the treatment of inflammatory bowel disease
by: Tsz Hong Yiu, et al.
Published: (2024)

Review article: Evidence‐based dietary management of inflammatory bowel disease
by: Peter R. Gibson, et al.
Published: (2024)

Editorial: Treatments for inflammatory bowel disease across the age‐spectrum—Are they the same?
by: Agnes Hiu Yan Ho, et al.
Published: (2024)

Metabolic dysfunction‐associated steatotic liver disease and MetALD increases the risk of liver cancer and gastrointestinal cancer: A nationwide cohort study
by: Yewan Park, et al.
Published: (2024)

Risk of Variceal Bleeding in Patients Receiving Atezolizumab–Bevacizumab Treatment for Hepatocellular Carcinoma
by: Kanghee Park, et al.
Published: (2025)

Letter: Thioguanine, an under‐utilised option in inflammatory bowel disease? Authors' reply
by: Abhinav Vasudevan, et al.
Published: (2024)

Letter: Allostatic load—A potential key in the development of inflammatory bowel disease
by: Maryam Kharal, et al.
Published: (2024)

Allostatic load increases the incidence and risk of adverse prognosis in inflammatory bowel disease
by: Jianhui Zhao, et al.
Published: (2024)

Editorial: Towards optimal thiopurine therapy for inflammatory bowel disease—authors' reply
by: Abhinav Vasudevan, et al.
Published: (2024)

Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis‐associated inflammatory bowel disease (PSC‐IBD): A matched analysis from the Paediatric PSC Consortium
by: Amanda Ricciuto, et al.
Published: (2024)

Review article: Optimisation of biologic (monoclonal antibody) therapeutic response in inflammatory bowel disease
by: Thanaboon Chaemsupaphan, et al.
Published: (2024)

Systematic review: Methotrexate—A poorly understood and underused medication in inflammatory bowel disease
by: Léa Sequier, et al.
Published: (2024)

Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remission
by: Arta Aliu, et al.
Published: (2024)

Letter: Light in the lumen—The expanding role of intestinal ultrasound for functional symptoms in inflammatory bowel disease
by: R. M. Mathias, et al.
Published: (2024)

Review article: The role of the gut–brain axis in inflammatory bowel disease and its therapeutic implications
by: Christy Riggott, et al.
Published: (2024)

Letter: Diet‐microbiome interactions in inflammatory bowel disease—Navigating towards individualised dietary strategies
by: Iris Barth, et al.
Published: (2024)

Letter: Microbial manipulation for primary sclerosing cholangitis‐associated inflammatory bowel disease—hope on the horizon
by: D. Bogatic, et al.
Published: (2024)

Risk Prediction of Early‐Onset Hepatocellular Carcinoma: Derivation and Validation in a Nationwide Young Adult Cohort
by: Seogsong Jeong, et al.
Published: (2026)

Editorial: How to Interpret Clinical Impact of Viral Replication Activity for Postoperative Recurrence of HBV‐Related HCC
by: Beom Kyung Kim
Published: (2025)

Editorial: Updated epidemiology of steatotic liver disease in people with HIV in the United States
by: Richie Manikat, et al.
Published: (2024)

Editorial: Is it time to include oral vancomycin in therapeutic guidelines for primary sclerosing cholangitis‐associated inflammatory bowel disease?
by: Ayesha Shah, et al.
Published: (2024)

Use of glucagon‐like peptide‐1 receptor agonists for type 2 diabetes mellitus and outcomes of inflammatory bowel disease
by: Aakash Desai, et al.
Published: (2024)

The contribution of dietary advanced glycation end‐products and genetic risk in the development of inflammatory bowel disease: a prospective cohort study
by: Fangyuan Jiang, et al.
Published: (2024)

Treatment of inflammatory bowel disease with steroid‐sparing medications is age‐dependent – Results from a Danish nationwide cohort study, 2000–2018
by: Rie Louise Møller Nordestgaard, et al.
Published: (2024)

Letter on ‘Association Between Viral Replication Activity and Postoperative Recurrence of HBV‐Related Hepatocellular Carcinoma’
by: Dong Hyun Kim, et al.
Published: (2025)

Editorial: Using machine learning to predict significant fibrosis in metabolic dysfunction‐associated steatotic liver disease
by: Richie Manikat, et al.
Published: (2024)

Letter on ‘Long‐Term Dynamic Changes of Alanine Aminotransferase Levels Are Associated With Liver‐Related Events in Nucleos(t)ide Analogue‐Treated Chronic Hepatitis B Patients in China’
by: Dong Hyun Kim, et al.
Published: (2025)

Letter on “Immigration Factors and Monitoring of Chronic Hepatitis B Infection Among Foreign‐Born: The FOCUS‐HBV Multicentre Cohort”
by: Dong Hyun Kim, et al.
Published: (2025)

Editorial: Advancing HCC Surveillance in Hepatitis B With Biomarker‐Based Strategy
by: Yu Jun Wong
Published: (2025)

Letter: Irritable bowel syndrome and antibiotics
by: George F. Longstreth
Published: (2024)

Inflammatory bowel disease in 2024 and beyond
by: Richard B. Gearry, et al.
Published: (2024)